12
NPS Score
VS
23andMe Claimed Company
- EMPLOYEE
PARTICIPANTS - 37
- TOTAL
RATINGS
Denali Therapeutics
- EMPLOYEE
PARTICIPANTS - 6
- TOTAL
RATINGS
23andMe vs Denali Therapeutics
Compare 23andMe versus Denali Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 37 employees and customers of 23andMe and 6 employees and customers of Denali Therapeutics.
23andMe
23andMe's brand is ranked #643 in the list of Global Top 1000 Brands, as rated by customers of 23andMe. Their current market cap is $2.50B.
Denali Therapeutics
Denali Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Denali Therapeutics. Their current valuation is $4.32B.
3.7/5
Product Quality
3.8/5
3.3/5
Pricing
4.7/5
3.3/5
Customer Service
4.5/5
| 49% | Promoters |
|---|---|
| 14% | Passive |
| 37% | Detractors |
67
NPS Score
| 67% | Promoters |
|---|---|
| 33% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 55
See how 23andMe compares to its competitors
See how Denali Therapeutics compares to its competitors
Working at 23andMe vs Working at Denali Therapeutics
77 / 100
CEO Rating
82 / 100
CEO Rating
Winner by 5%
23andMe
23andMe doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Denali Therapeutics
Employees at Denali Therapeutics rate their CEO, Ryan Watts, 82/100. This score is 5% higher than the scores of 23andMe's CEO, Anne Wojcicki.